NEWS POST: New Treatment For Leukemia Patients
New research published in Friday’s i paper showed the current swathes of progress in the fight against cancer. The article reported on a study that took place at the Memorial Sloan-Kettering Cancer Centre in New York, which concentrated on cancer patients that had previously undergone chemotherapy to treat cancer but had subsequently relapsed. The cancer patients in question each suffered from a form of cancer that affects white blood cells, B-cell acute lymphoblastic leukemia. Although each patient responded positively to chemotherapy, the cancer soon returned with gusto, boasting a resistance to any further treatments of chemotherapy. However, new treatments developed by the Kettering Cancer Centre allowed patients to be injected with a modification of their own cancer fighting gene to fight the disease. The treatment, known as targeted immunotherapy, involves inserting an additional gene into the patient’s white blood cells that allow them to identify the cancerous cells